NCT00297258 - Pazopanib In Patients With Relapsed Or Refractory Soft Tissue Sarcoma | Biotech Hunter

Enrollment

148

Participants

Timeline

Start Date

November 30, 2005

Primary Completion Date

February 28, 2014

Study Completion Date

February 28, 2014

Conditions

Sarcoma, Soft Tissue

Interventions

DRUG

pazopanib

oral tablet

Trial Locations (16)

1000

GSK Investigational Site, Brussels

3000

GSK Investigational Site, Leuven

13385

GSK Investigational Site, Marseille

69437

GSK Investigational Site, Lyon

75248

GSK Investigational Site, Paris

94805

GSK Investigational Site, Villejuif

01135

GSK Investigational Site, Budapest

9713 GZ

GSK Investigational Site, Groningen

2300 RC

GSK Investigational Site, Leiden

3075 EA

GSK Investigational Site, Rotterdam

M20 4BX

GSK Investigational Site, Manchester

G11 6NT

GSK Investigational Site, Glasgow

LS9 7TF

GSK Investigational Site, Leeds

SW3 6JJ

GSK Investigational Site, London

NE7 7DN

GSK Investigational Site, Newcastle upon Tyne

S10 2SJ

GSK Investigational Site, Sheffield